References
- BahnRSGraves’ ophthalmopathyN Engl J Med2010362872673820181974
- Abraham-NordlingMWallinGTräiskFThyroid Study Group of TT 96Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodineEur J Endocrinol201016365165720660002
- TjiangHLahootiHMcCorquodaleTParmarKRWallJREye and eyelid abnormalities are common in patients with Hashimoto’s thyroiditisThyroid20102028729020146657
- LahootiHParmarKRWallJRPathogenesis of Thyroid Eye Disease: important role of autoimmunity against calsequestrin and collagen XIII. Pathogenesis of Thyroid Eye Disease: important role of autoimmunity against calsequestrin and collagen XIII. A reviewClin Ophthalmol20101441742520505833
- GopinathBTaniJBaoNWallJREye muscle and collagen XIII antibodies and eye signs in patients with transient and chronic thyroiditisThyroid2007171717274740
- KhalilzadehONoshadSRashidiAAmirzargarAGraves’ ophthalmopathy: a review of immunogeneticsCurr Genomics20111256457522654556
- LiaoWLWanLWangTYAssociation of TLR7 and TSHR copy number variation with Graves’ disease and Graves’ ophthalmopathy in Chinese population in TaiwanBMC Ophthalmol2014141524517461
- YamadaMWu LiAWallJThyroid-associated ophthalmopathy: clinical features, pathogenesis, and managementCrit Rev Clin Lab Sci200037652354911192331
- GirgisCMChampionBLWallJRCurrent concepts in Graves’ diseaseTher Adv Endocrinol Metab20112313514423148179
- McCorquodaleTLahootiHGopinathBWallJRLong-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathyClin Ophthalmol201261063107122888204
- TaniJGopinathBNuygenBWallJRImmunological mechanisms for the eye muscle and orbital connective tissue reactions of thyroid-associated ophthalmopathyExp Rev Clin Immunol20073299311
- GopinathBMusselmanRBeardNTaniJAdamsCWallJRAntibodies targeting the calcium binding skeletal muscle protein calsequestrin are sensitive and specific markers of ocular myopathy in patients with Graves’ diseaseClin Exp Immunol2006145566216792674
- NuneryWRMartinRTHinzGWGavinTJThe association of cigarette smoking with clinical subtypes of ophthalmic Graves’ diseaseOphthal Plast Reconstr Surg199397782
- GopinathBAdamsCLMusselmanRTaniJWallJRAntibodies against calsequestrin and type XIII collagen are good markers for chronic upper eyelid lag and retractionOcular Immunol Inflammation2007158188
- WallJRLahootiHPathogenesis of thyroid eye disease – does autoimmunity against the TSH Receptor explain all cases?Endokrynol Pol201061222222720464711
- GopinathBMusselmanRAdamsCTaniJBeardNWallJRStudy of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves’ disease with and without ophthalmopathy – correlation with clinical featuresThyroid20061696797417042681
- NguyenBGopinathBTaniJWescombeLWallJRPeripheral blood T lymphocyte sensitization against calsequestrin and flavoprotein in patients with Graves’ ophthalmopathyAutoimmunity20084137237618568642
- GopinathBWescombeLNguyenBWallJRCan Autoimmunity against calsequestrin explain the eye and eyelid muscle inflammation of thyroid eye disease?Orbit20092825626119839885
- TaniJWallJRAnalysis – Can the development of thyroid-associated ophthalmopathy be explained by autoimmunity against eye muscle antigens?Canad Med Assoc200617239241
- de HaanSLahootiHMorrisOWallJREpitopes, immunoglobulin classes and immunoglobulin G subclasses of calsequestrin antibodies in patients with thyroid eye diseaseAutoimmunity201043869870320670117
- PorterJDKhannaSKaminskiHJExtraocular muscle is defined by a fundamentally distinct gene expression profilePNAS200198120621206711572940
- WescombeLLahootiHGopinathBWallJRThe cardiac calsequestrin gene (CASQ2) is up-regulated in the thyroid in patients with Graves’ ophthalmopathy – support for a role of autoimmunity against calsequestrin as the triggering eventClin Endocrinol (Oxf)20107352252820039900
- LahootiHCultroneDEdirimanneSAssociation of the CASQ1 gene SNP rs3838216 with ophthalmopathy in patients with thyroid autoimmunityOphthalmol Res201426281293
- WalshJPBerryJLiuSThe clinical presentation of autoimmune thyroid disease in men is associated with IL12B genotypeClin Endocrinol (Oxf)201174450851221198744
- MouritsMPKoornneefLWiersingaWMPrummelMFBerghoutAvan der GaagRClinical criteria for the assessment of disease activity in Grave’s ophthalmopathy: a novel approachBr J Ophthalmol1989736396442765444
- WernerSCClassification of the eye changes of Graves’ diseaseAm J Ophthalmol1969686466485394450
- CultroneDLahootiHEdirimanneSDelbridgeLChampionBWallJRCalsequestrin is decreased in the thyroid gland of patients with Graves’ disease – further evidence for a role of autoimmunity against this protein in Graves’ ophthalmopathyBr J Med Med Res201442340654075
- StanMNBahnRSRisk factors for development or deterioration of Graves’ ophthalmopathyThyroid201020777778320578901
- DaviesTFLatifRYinXNew genetic insights from autoimmune thyroid diseaseJ Thyroid Res2012201262385222530160